Stay updated on Pembrolizumab in Thymic Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Thymic Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.5.2 to v3.5.3. This indicates a small back-end update to the page that does not appear to affect the study content or data.
    Difference
    0.1%
    Check dated 2026-04-30T15:36:45.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T09:51:12.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T20:24:45.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A new publication citation was added to Publications, and an erratum citation was removed.
    Difference
    0.1%
    Check dated 2026-03-18T14:39:44.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T14:50:39.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Added a new publication citation on PD-1 therapy in solid tumors and removed the previous citation.
    Difference
    0.1%
    Check dated 2026-02-25T06:58:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Thymic Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.